Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Radioimmunotherapy cures human non-Hodgkin lymphoma in animal model

A new nuclear medicine therapy can cure human non-Hodgkin lymphoma in an animal model, according to research published in the April issue of The Journal of Nuclear Medicine.

11 Apr 2023

Financial impact of a loved one's cancer diagnosis impacts partner's quality of life

A cancer diagnosis can cause financial strain on patients as they cope with the cost of treatment and lost work. But what about their partners?

11 Apr 2023

Using tiny bubbles to improve gene therapy

Beyond vaccines, mRNA offers immense potential to fight disease, but targeting the genetic material to specific diseased cells is challenging - requiring a new method.

11 Apr 2023

'We can with Tecan' competition offers an extra pair of hands to innovative NGS-based researchers

Tecan is excited to introduce its We can with Tecan competition, which will recognize the ground-breaking achievements in the field of NGS and reward two winners with their very own MagicPrep™ NGS instruments*.

From Tecan 11 Apr 2023

Lack of therapeutic markers leads to poorer outcomes in triple negative breast cancer

A new review paper was published in Oncotarget's Volume 14 on March 31, 2023, entitled, "Crosstalk between triple negative breast cancer and microenvironment."

10 Apr 2023

Immunotherapy response in patients with advanced melanoma depends on prior treatments

Research led by scientists at UCLA Jonsson Comprehensive Cancer Center found that responses to a type of immunotherapy called PD-1 checkpoint blockade in patients with advanced melanoma depended on whether or not they had previously received another immunotherapy – CTLA-4 blockade – as well as other factors.

10 Apr 2023

ACC to host annual Advancing the Cardiovascular Care of the Oncology Patient course

The American College of Cardiology will host the annual Advancing the Cardiovascular Care of the Oncology Patient course on April 14-16, 2023, in Washington, DC.

10 Apr 2023

For uninsured people with cancer, securing care can be like spinning a roulette wheel

Eighteen months after April Adcox learned she had skin cancer, she finally returned to Charleston's Medical University of South Carolina last May to seek treatment.

10 Apr 2023

DPE analysis may help improve the diagnosis and management of colorectal cancer

A new editorial paper was published in Oncoscience (Volume 10) on March 23, 2023, entitled, "New method of clustering colorectal cancer patients using differential presence of exons (DPE) sequencing."

7 Apr 2023

Study opens new possibilities of tailoring radiopharmaceutical treatment to neuroendocrine cancer patients

A simple blood draw can provide physicians with valuable information that can determine if peptide receptor radionuclide therapy (PRRT) is likely to be effective in a patient with neuroendocrine cancer.

7 Apr 2023

Epidural electrical stimulation stabilizes blood pressure in patients suffering from spinal cord injury

An implant that delivers electrical stimulation to a select group of spinal neurons can treat dangerously low blood pressure in people with spinal cord injuries, addressing an often "invisible" consequence of paralysis.

7 Apr 2023

Phase 2 study shows safety and efficacy of new drug in men with high-risk prostate cancers

A new drug, a monoclonal antibody known as enoblituzumab, is safe in men with aggressive prostate cancer and may induce clinical activity against cancer throughout the body, according to a phase 2 study led by investigators at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy.

6 Apr 2023

Childhood cancer survivors maintaining a healthy lifestyle may have lower risk of mortality

A report from the Childhood Cancer Survivor Study provides strong evidence of the importance of a healthy lifestyle for adults who were treated for cancer as children.

5 Apr 2023

Novel combination treatment for head and neck cancers leads to antitumor effects

Human papillomavirus (HPV)-negative head and neck squamous cell carcinoma (HNSCC) and lung cancer can have disruptive mutations in TP53and/or CDKN2A tumor suppressor genes, which are associated with poor patient survival.

5 Apr 2023

St. Jude computational biologists characterize the full spectrum of oncogenic fusions in pediatric cancer

The scientific foundation needed to work on curing a class of cancer-causing mutations is here, in the form of a tool from St. Jude Children's Research Hospital.

5 Apr 2023

International panel develops standardized definitions of immunotherapy side effects

An international panel of oncology and immunotherapy experts led by RCSI's Professor Jarushka Naidoo, has developed standardized definitions of the side effects of cancer immunotherapy to assist clinicians in treating patients.

5 Apr 2023

Mosaic Therapeutics closes $28m series A funding and appoints Brian Gladsden as CEO

Mosaic Therapeutics, an oncology therapeutics company dedicated to resolving cancer’s complexity to power new treatments for patients, today announced the close of its $28 million series A funding round.

From Mosaic Therapeutics 4 Apr 2023

New approach to primary palliative care increases uptake of advance care planning among patients with advanced cancer

New research in the April 2023 issue of JNCCN - Journal of the National Comprehensive Cancer Network finds that specially trained oncology infusion room nurses can improve advance care planning (ACP) for patients with advanced cancer.

4 Apr 2023

Clinical trial may change the paradigm of care for patients with ALK-driven high-risk neuroblastoma

In a significant step for the treatment of neuroblastoma, an international group of researchers led by Children's Hospital of Philadelphia (CHOP), Winship Cancer Institute of Emory University and the New Approaches to Neuroblastoma Therapy (NANT) Consortium has shown that the targeted therapy lorlatinib is safe and effective in treating high-risk neuroblastoma.

4 Apr 2023

Live attenuated nasal vaccine elicits superior immunity to SARS-CoV-2 variants in hamsters

Since the beginning of the COVID-19 pandemic, researchers have been working on mucosal vaccines that can be administered through the nose.

4 Apr 2023

Oncology News and Research

Further Reading

Radioimmunotherapy cures human non-Hodgkin lymphoma in animal model

Financial impact of a loved one's cancer diagnosis impacts partner's quality of life

Using tiny bubbles to improve gene therapy

'We can with Tecan' competition offers an extra pair of hands to innovative NGS-based researchers

Lack of therapeutic markers leads to poorer outcomes in triple negative breast cancer

Immunotherapy response in patients with advanced melanoma depends on prior treatments

ACC to host annual Advancing the Cardiovascular Care of the Oncology Patient course

For uninsured people with cancer, securing care can be like spinning a roulette wheel

DPE analysis may help improve the diagnosis and management of colorectal cancer

Study opens new possibilities of tailoring radiopharmaceutical treatment to neuroendocrine cancer patients

Epidural electrical stimulation stabilizes blood pressure in patients suffering from spinal cord injury

Phase 2 study shows safety and efficacy of new drug in men with high-risk prostate cancers

Childhood cancer survivors maintaining a healthy lifestyle may have lower risk of mortality

Novel combination treatment for head and neck cancers leads to antitumor effects

St. Jude computational biologists characterize the full spectrum of oncogenic fusions in pediatric cancer

International panel develops standardized definitions of immunotherapy side effects

Mosaic Therapeutics closes $28m series A funding and appoints Brian Gladsden as CEO

New approach to primary palliative care increases uptake of advance care planning among patients with advanced cancer

Clinical trial may change the paradigm of care for patients with ALK-driven high-risk neuroblastoma

Live attenuated nasal vaccine elicits superior immunity to SARS-CoV-2 variants in hamsters

A best-practice guide for laboratory services in oncology trials eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News